Report Detail

Pharma & Healthcare Global and Japan Pertuzumab Market Insights, Forecast to 2026

  • RnM4174909
  • |
  • 31 August, 2020
  • |
  • Global
  • |
  • 129 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Pertuzumab Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Pertuzumab Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Pertuzumab Market Size Growth Rate by Type
    • 1.4.2 Human Source
    • 1.4.3 Animal Source
  • 1.5 Market by Application
    • 1.5.1 Global Pertuzumab Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Medical Center
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Pertuzumab Market Size, Estimates and Forecasts
    • 2.1.1 Global Pertuzumab Revenue 2015-2026
    • 2.1.2 Global Pertuzumab Sales 2015-2026
  • 2.2 Global Pertuzumab, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Pertuzumab Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Pertuzumab Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Pertuzumab Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Pertuzumab Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Pertuzumab Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Pertuzumab Revenue Forecast by Region (2021-2026)

3 Global Pertuzumab Competitor Landscape by Players

  • 3.1 Global Top Pertuzumab Sales by Manufacturers
    • 3.1.1 Global Pertuzumab Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Pertuzumab Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Pertuzumab Manufacturers by Revenue
    • 3.2.1 Global Pertuzumab Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Pertuzumab Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Pertuzumab Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Pertuzumab Revenue in 2019
    • 3.2.5 Global Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Pertuzumab Price by Manufacturers
  • 3.4 Global Pertuzumab Manufacturing Base Distribution, Product Types
    • 3.4.1 Pertuzumab Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Pertuzumab Product Type
    • 3.4.3 Date of International Manufacturers Enter into Pertuzumab Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Pertuzumab Market Size by Type (2015-2020)
    • 4.1.1 Global Pertuzumab Sales by Type (2015-2020)
    • 4.1.2 Global Pertuzumab Revenue by Type (2015-2020)
    • 4.1.3 Pertuzumab Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Pertuzumab Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Pertuzumab Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Pertuzumab Revenue Forecast by Type (2021-2026)
    • 4.2.3 Pertuzumab Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Pertuzumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Pertuzumab Market Size by Application (2015-2020)
    • 5.1.1 Global Pertuzumab Sales by Application (2015-2020)
    • 5.1.2 Global Pertuzumab Revenue by Application (2015-2020)
    • 5.1.3 Pertuzumab Price by Application (2015-2020)
  • 5.2 Pertuzumab Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Pertuzumab Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Pertuzumab Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Pertuzumab Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan Pertuzumab Market Size YoY Growth 2015-2026
    • 6.1.1 Japan Pertuzumab Sales YoY Growth 2015-2026
    • 6.1.2 Japan Pertuzumab Revenue YoY Growth 2015-2026
    • 6.1.3 Japan Pertuzumab Market Share in Global Market 2015-2026
  • 6.2 Japan Pertuzumab Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top Pertuzumab Players by Sales (2015-2020)
    • 6.2.2 Japan Top Pertuzumab Players by Revenue (2015-2020)
  • 6.3 Japan Pertuzumab Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan Pertuzumab Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan Pertuzumab Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan Pertuzumab Price by Type (2015-2020)
  • 6.4 Japan Pertuzumab Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan Pertuzumab Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan Pertuzumab Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan Pertuzumab Price Forecast by Type (2021-2026)
  • 6.5 Japan Pertuzumab Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan Pertuzumab Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan Pertuzumab Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan Pertuzumab Price by Application (2015-2020)
  • 6.6 Japan Pertuzumab Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan Pertuzumab Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan Pertuzumab Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan Pertuzumab Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Pertuzumab Market Size YoY Growth 2015-2026
  • 7.2 North America Pertuzumab Market Facts & Figures by Country
    • 7.2.1 North America Pertuzumab Sales by Country (2015-2020)
    • 7.2.2 North America Pertuzumab Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Pertuzumab Market Size YoY Growth 2015-2026
  • 8.2 Europe Pertuzumab Market Facts & Figures by Country
    • 8.2.1 Europe Pertuzumab Sales by Country
    • 8.2.2 Europe Pertuzumab Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Pertuzumab Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Pertuzumab Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Pertuzumab Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Pertuzumab Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Pertuzumab Market Size YoY Growth 2015-2026
  • 10.2 Latin America Pertuzumab Market Facts & Figures by Country
    • 10.2.1 Latin America Pertuzumab Sales by Country
    • 10.2.2 Latin America Pertuzumab Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Pertuzumab Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Pertuzumab Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Pertuzumab Sales by Country
    • 11.2.2 Middle East and Africa Pertuzumab Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Novartis AG
    • 12.1.1 Novartis AG Corporation Information
    • 12.1.2 Novartis AG Description and Business Overview
    • 12.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Novartis AG Pertuzumab Products Offered
    • 12.1.5 Novartis AG Recent Development
  • 12.2 Pfizer
    • 12.2.1 Pfizer Corporation Information
    • 12.2.2 Pfizer Description and Business Overview
    • 12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Pfizer Pertuzumab Products Offered
    • 12.2.5 Pfizer Recent Development
  • 12.3 Abnova Corporation
    • 12.3.1 Abnova Corporation Corporation Information
    • 12.3.2 Abnova Corporation Description and Business Overview
    • 12.3.3 Abnova Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Abnova Corporation Pertuzumab Products Offered
    • 12.3.5 Abnova Corporation Recent Development
  • 12.4 InvivoGen
    • 12.4.1 InvivoGen Corporation Information
    • 12.4.2 InvivoGen Description and Business Overview
    • 12.4.3 InvivoGen Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 InvivoGen Pertuzumab Products Offered
    • 12.4.5 InvivoGen Recent Development
  • 12.5 Celltrion
    • 12.5.1 Celltrion Corporation Information
    • 12.5.2 Celltrion Description and Business Overview
    • 12.5.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Celltrion Pertuzumab Products Offered
    • 12.5.5 Celltrion Recent Development
  • 12.6 Biocon Limited
    • 12.6.1 Biocon Limited Corporation Information
    • 12.6.2 Biocon Limited Description and Business Overview
    • 12.6.3 Biocon Limited Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Biocon Limited Pertuzumab Products Offered
    • 12.6.5 Biocon Limited Recent Development
  • 12.7 Bio-Techne
    • 12.7.1 Bio-Techne Corporation Information
    • 12.7.2 Bio-Techne Description and Business Overview
    • 12.7.3 Bio-Techne Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Bio-Techne Pertuzumab Products Offered
    • 12.7.5 Bio-Techne Recent Development
  • 12.11 Novartis AG
    • 12.11.1 Novartis AG Corporation Information
    • 12.11.2 Novartis AG Description and Business Overview
    • 12.11.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Novartis AG Pertuzumab Products Offered
    • 12.11.5 Novartis AG Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Pertuzumab Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Pertuzumab Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Pertuzumab market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pertuzumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Pertuzumab market is segmented into
    Human Source
    Animal Source

    Segment by Application, the Pertuzumab market is segmented into
    Hospital
    Medical Center

    Regional and Country-level Analysis
    The Pertuzumab market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Pertuzumab market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Pertuzumab Market Share Analysis
    Pertuzumab market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pertuzumab business, the date to enter into the Pertuzumab market, Pertuzumab product introduction, recent developments, etc.
    The major vendors covered:
    Novartis AG
    Pfizer
    Abnova Corporation
    InvivoGen
    Celltrion
    Biocon Limited
    Bio-Techne
    ...


    Summary:
    Get latest Market Research Reports on Pertuzumab. Industry analysis & Market Report on Pertuzumab is a syndicated market report, published as Global and Japan Pertuzumab Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Pertuzumab market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,005.32
    4,507.98
    6,010.64
    3,317.56
    4,976.34
    6,635.12
    406,883.10
    610,324.65
    813,766.20
    288,522.39
    432,783.58
    577,044.78
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report